Free Trial

Teza Capital Management LLC Makes New Investment in Axon Enterprise, Inc $AXON

Axon Enterprise logo with Aerospace background

Key Points

  • Teza Capital Management LLC acquired 532 shares of Axon Enterprise, valued at approximately $280,000, indicating growing interest from institutional investors in the company.
  • Insider Jeffrey C. Kunins sold 7,891 shares worth over $5.9 million, reflecting a 5.18% decrease in his ownership of the company.
  • Axon Enterprise reported $2.12 earnings per share for the last quarter, surpassing estimates and showing a 32.6% increase in revenue compared to the previous year.
  • MarketBeat previews top five stocks to own in October.

Teza Capital Management LLC acquired a new stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm acquired 532 shares of the biotechnology company's stock, valued at approximately $280,000.

A number of other hedge funds have also recently bought and sold shares of AXON. GAMMA Investing LLC boosted its position in Axon Enterprise by 58,725.5% in the 1st quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company's stock valued at $402,210,000 after buying an additional 763,431 shares during the last quarter. Jennison Associates LLC boosted its position in Axon Enterprise by 23,203.7% in the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company's stock valued at $322,961,000 after buying an additional 611,418 shares during the last quarter. Nuveen LLC bought a new position in shares of Axon Enterprise in the 1st quarter worth $264,796,000. Westfield Capital Management Co. LP boosted its position in shares of Axon Enterprise by 29.8% in the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company's stock worth $487,977,000 after purchasing an additional 212,931 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Axon Enterprise by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company's stock worth $4,540,005,000 after purchasing an additional 185,571 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Up 0.7%

Shares of NASDAQ:AXON traded up $5.02 during midday trading on Friday, reaching $756.13. The company had a trading volume of 303,694 shares, compared to its average volume of 447,052. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The business's 50 day moving average price is $761.10 and its 200 day moving average price is $688.38. The stock has a market cap of $59.36 billion, a PE ratio of 186.70, a P/E/G ratio of 27.75 and a beta of 1.40. Axon Enterprise, Inc has a 1-year low of $375.71 and a 1-year high of $885.91.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business's revenue was up 32.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CAO Jennifer H. Mak sold 75 shares of the business's stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $723.50, for a total transaction of $54,262.50. Following the completion of the transaction, the chief accounting officer directly owned 15,080 shares in the company, valued at $10,910,380. The trade was a 0.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Hadi Partovi purchased 1,358 shares of the company's stock in a transaction dated Wednesday, August 13th. The stock was purchased at an average price of $740.00 per share, with a total value of $1,004,920.00. Following the completion of the purchase, the director directly owned 237,938 shares in the company, valued at $176,074,120. The trade was a 0.57% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 44,790 shares of company stock valued at $34,304,947. 5.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research analysts have recently issued reports on AXON shares. UBS Group restated a "neutral" rating and issued a $840.00 price target (up from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Morgan Stanley set a $885.00 price target on Axon Enterprise and gave the stock an "overweight" rating in a research report on Friday, July 11th. Raymond James Financial restated an "outperform" rating and issued a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Craig Hallum upgraded Axon Enterprise from a "hold" rating to a "buy" rating and set a $900.00 price target on the stock in a research report on Tuesday, August 5th. Finally, Bank of America raised their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and an average target price of $837.69.

Read Our Latest Research Report on AXON

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Recommended Stories

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Should You Invest $1,000 in Axon Enterprise Right Now?

Before you consider Axon Enterprise, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.

While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.